Perrigo Company Plc

pharmaceutical company

PRGO NYSE ISIN IE00BGH1M568 SEC CIK 1585364 LEI 549300IFOQS6R1QLY196
Follow Perrigo Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $988.6M −5.2% vs same quarter last year
Net income −$27.5M −466.7% vs same quarter last year
EPS, diluted −$0.20 −500% vs same quarter last year
Operating cash flow $96.2M +86.1% vs same quarter last year
Revenue by quarter
$1.1B
$1B
$1.1B
$1B
$1.1B
$969.2M
$1B
$988.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$5B−$2.5B$0$2.5B$5B$7.5BFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.3B−$1.4B
FY24$4.4B−$171.8M
FY23$4.7B−$12.7M
FY22$4.5B−$140.6M
FY21$4.1B−$68.9M
FY20$4.1B−$162.6M
FY19$3.9B$146.1M
FY18$4.7B$131M
FY17$4.9B$119.6M
FY16$5.3B−$4B
FY15$4.2B$136.1M
FY14$3.9B$232.8M
FY13$800K$441.9M
FY12$3.2B$401.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−25000%0%25000%50000%75000%100000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2535.1%−26.4%−33.5%
FY2435.3%2.6%−3.9%
FY2336.1%3.3%−0.3%
FY2232.7%1.8%−3.2%
FY2134.2%9.9%−1.7%
FY2036.6%6.5%−4%
FY1937%4.5%3.8%
FY1838.7%5%2.8%
FY1740%12.1%2.4%
FY1638.9%−37.9%−76%
FY1538.9%15.9%3.2%
FY1437.1%14.6%5.9%
FY13-84887.5%55237.5%
FY1234.5%17.9%12.7%
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600M$800MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$145.1M
FY24$244.6M
FY23$303.8M
FY22$210.9M
FY21$4.2M
FY20$465.8M
FY19$250.1M
FY18$490.4M
FY17$610.3M
FY16$548.7M
FY15$718.2M
FY14$461.4M
FY13$449.7M
FY12$393.2M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200M$400M$600MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$159.3M-
FY24$152.5M-
FY23$149.7M-
FY22$142.4M$0
FY21$129.6M$0
FY20$123.9M$164.2M
FY19$112.4M$0
FY18$104.9M$400M
FY17$91.1M$191.5M
FY16$83.2M$0
FY15$64.8M$0
FY14$46.1M$0
FY13$33M$0
FY12$29M$8.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Perrigo
  • Healthcare median
−20000%0%20000%40000%60000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPerrigoHealthcare median
FY25−33.5%−30.6%
FY24−3.9%−47%
FY23−0.3%−58%
FY22−3.2%−80.4%
FY21−1.7%−71.9%
FY20−4%−62.2%
FY193.8%−46.3%
FY182.8%−49.6%
FY172.4%−45.9%
FY16−76%−36%
FY153.2%−38.4%
FY145.9%−35.5%
FY1355237.5%−37.1%
FY1212.7%−29.1%